Francesco Romeo, MD, FACC, FESC
- 2Articles
- 5.9KReads1
- 2006–2008Active
- 12Collaborators
About
Francesco Romeo, MD, FACC, FESC, has published research on the cardiac effects of antipsychotic coadministration and the inflammatory and prothrombotic markers associated with major depressive disorder. His work includes clinical studies on asymptomatic QTc prolongation during treatment with aripiprazole and haloperidol, as well as investigations into the impact of selective serotonin reuptake inhibitor therapy on soluble CD40 ligand levels in depression. His publications span topics related to depression and schizophrenia/schizoaffective disorders.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
